Cargando…

Epigenetic activation of FOXF1 confers cancer stem cell properties to cisplatin-resistant non-small cell lung cancer

The underlying molecular mechanisms of cisplatin resistance in non-small cell lung cancer (NSCLC) are unclear. In this study, a novel differential methylation region located in the upstream regulatory region of the forkhead box F1 (FOXF1) gene was identified. The abnormal hypomethylation of FOXF1 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jian, Xue, Xingyang, Fu, Wenfan, Dai, Lu, Jiang, Zeyong, Zhong, Shengpeng, Deng, Boyun, Yin, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115358/ https://www.ncbi.nlm.nih.gov/pubmed/32319573 http://dx.doi.org/10.3892/ijo.2020.5003

Ejemplares similares

Epigenetic activation of hepatocyte growth factor is associated with epithelial-mesenchymal transition and clinical outcome in non-small cell lung cancer
por: Yin, Jun, et al.
Publicado: (2019)

HGF/MET Regulated Epithelial-Mesenchymal Transitions And Metastasis By FOSL2 In Non-Small Cell Lung Cancer
por: Yin, Jun, et al.
Publicado: (2019)

LINC01224/ZNF91 Promote Stem Cell-Like Properties and Drive Radioresistance in Non-Small Cell Lung Cancer
por: Fu, Wenfan, et al.
Publicado: (2021)

The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer
por: Zhao, Jian, et al.
Publicado: (2015)

let-7 and miR-17 promote self-renewal and drive gefitinib resistance in non-small cell lung cancer
por: Yin, Jun, et al.
Publicado: (2019)

ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1
por: Yin, Jun, et al.
Publicado: (2017)

miRNA 17 Family Regulates Cisplatin-Resistant and Metastasis by Targeting TGFbetaR2 in NSCLC
por: Jiang, Zeyong, et al.
Publicado: (2014)

Long non-coding RNA PVT1 facilitates cell proliferation by epigenetically regulating FOXF1 in breast cancer
por: Guo, Guangcheng, et al.
Publicado: (2018)

Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer
por: Kong, Peng-Zhou, et al.
Publicado: (2016)

FOXF2 reprograms breast cancer cells into bone metastasis seeds
por: Wang, Shuo, et al.
Publicado: (2019)

Retraction: Long non-coding RNA PVT1 facilitates cell proliferation by epigenetically regulating FOXF1 in breast cancer
por: Guo, Guangcheng, et al.
Publicado: (2022)

FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells
por: Wei, Hong-Jian, et al.
Publicado: (2014)

Cell adhesion molecule 2 (CADM2) promotes brain metastasis by inducing epithelial-mesenchymal transition (EMT) in human non-small cell lung cancer
por: Dai, Lu, et al.
Publicado: (2020)

Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway
por: Kun-Peng, Zhu, et al.
Publicado: (2017)

FOXF2 Regulates PRUNE2 Transcription in the Pathogenesis of Colorectal Cancer
por: Li, Ting, et al.
Publicado: (2022)

EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations
por: Gao, Jing, et al.
Publicado: (2016)

Highly Expressed FOXF1 Inhibit Non-Small-Cell Lung Cancer Growth via Inducing Tumor Suppressor and G1-Phase Cell-Cycle Arrest
por: Wu, Chia-Yu, et al.
Publicado: (2020)

Genomic and Epigenetic Complexity of the FOXF1 Locus in 16q24.1: Implications for Development and Disease
por: Dharmadhikari, Avinash V., et al.
Publicado: (2015)

Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells
por: Miao, Liyun, et al.
Publicado: (2016)

Comparison of the profiles of first-line PD-1/PD-L1 inhibitors for advanced NSCLC lacking driver gene mutations: a systematic review and Bayesian network meta-analysis
por: Wenfan, Fu, et al.
Publicado: (2023)

Aberrant DNA Methylation-Mediated FOXF2 Dysregulation Is a Prognostic Risk Factor for Gastric Cancer
por: Zhang, Cheng, et al.
Publicado: (2021)

Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity
por: Jia, Deyong, et al.
Publicado: (2022)

Lung endothelial cells regulate pulmonary fibrosis through FOXF1/R-Ras signaling
por: Bian, Fenghua, et al.
Publicado: (2023)

Association of ALDH1A1-NEK-2 axis in cisplatin resistance in ovarian cancer cells
por: Uddin, Md. Hafiz, et al.
Publicado: (2020)

Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells
por: Zhou, Huiling, et al.
Publicado: (2023)

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017)

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017)

FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer
por: Wang, Qing-Shan, et al.
Publicado: (2015)

Long non-coding RNA FOXF1 adjacent non-coding developmental regulatory RNA inhibits growth and chemotherapy resistance in non-small cell lung cancer
por: Xu, Ran, et al.
Publicado: (2019)

FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway
por: Zhang, Xiao, et al.
Publicado: (2022)

FoxF1 and FoxF2 transcription factors synergistically promote Rhabdomyosarcoma carcinogenesis by repressing transcription of p21(Cip1) CDK inhibitor
por: Milewski, David, et al.
Publicado: (2016)

FOXF2 inhibits proliferation, migration, and invasion of Hela cells by regulating Wnt signaling pathway
por: Zhang, Jun, et al.
Publicado: (2018)

MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer
por: Hirata, Hiroshi, et al.
Publicado: (2013)

MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer
por: Zhang, Xingzeng, et al.
Publicado: (2017)

FOXF1 Induces Epithelial-Mesenchymal Transition in Colorectal Cancer Metastasis by Transcriptionally Activating SNAI1()()
por: Wang, Shuyang, et al.
Publicado: (2018)

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
por: Stathopoulos, G. P., et al.
Publicado: (2011)

The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer
por: O'Byrne, Kenneth J., et al.
Publicado: (2011)

Epigenetic reprogramming in small cell lung cancer
por: Chen, Jingyao, et al.
Publicado: (2022)

Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin
por: Takahashi, Ryosuke, et al.
Publicado: (2023)

Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity
por: Wang, Lihui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5v67dbom1imm8lrh5am1k6d3j1